Q32 Bio Inc. (QTTB) EBT Margin (2018 - 2023)

Q32 Bio has reported EBT Margin for 6 years, with the latest figure at 1971.62% in Q4 2023.

• On a quarterly basis, EBT Margin rose 609119.0% year-over-year to 1971.62% in Q4 2023; TTM through Sep 2024 was 4318.6%, a 499544.0% increase from a year earlier, with the FY2025 full-year figure at 55.49%, changed N/A from the prior year.
• EBT Margin was 1971.62% for Q4 2023 at Q32 Bio, up from 751.26% in the prior quarter.
• The five-year high for EBT Margin was 11678.68% in Q1 2022, with the low at 8834.07% in Q1 2019.
• Average EBT Margin over 5 years is 2663.06%, with a median of 3704.86% recorded in 2022.
• The sharpest annual moves came in 2022 and 2023: EBT Margin surged 1168234 bps in 2022, then plunged 1191071 bps in 2023.
• Over 5 years, EBT Margin stood at 4292.54% in 2019, then increased by 29 bps to 3039.9% in 2020, then plunged by 38 bps to 4187.41% in 2021, then increased by 2 bps to 4119.58% in 2022, then soared by 148 bps to 1971.62% in 2023.
• The last three EBT Margin figures came in at 1971.62% (Q4 2023), 751.26% (Q3 2023), and 181.19% (Q2 2023), per Business Quant data.